Attached files
| file | filename |
|---|---|
| 10-K - 10-K - PONIARD PHARMACEUTICALS, INC. | a2197312z10-k.htm |
| EX-32.2 - EXHIBIT 32.2 - PONIARD PHARMACEUTICALS, INC. | a2197312zex-32_2.htm |
| EX-23.2 - EXHIBIT 23.2 - PONIARD PHARMACEUTICALS, INC. | a2197312zex-23_2.htm |
| EX-31.1 - EXHIBIT 31.1 - PONIARD PHARMACEUTICALS, INC. | a2197312zex-31_1.htm |
| EX-23.1 - EXHIBIT 23.1 - PONIARD PHARMACEUTICALS, INC. | a2197312zex-23_1.htm |
| EX-10.21 - EXHIBIT 10.21 - PONIARD PHARMACEUTICALS, INC. | a2197312zex-10_21.htm |
| EX-31.2 - EXHIBIT 31.2 - PONIARD PHARMACEUTICALS, INC. | a2197312zex-31_2.htm |
Exhibit 32.1
Certification of Annual Report
I, Ronald A. Martell, Chief Executive Officer of Poniard Pharmaceuticals, Inc. (the "Company"), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:
- 1.
- the
Annual Report on Form 10-K for the Company for the year ended December 31, 2009 (the "Report") fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (12 U.S.C. 78m or 78o(d)); and
- 2.
- the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Date: March 16, 2010 | By: | /s/ RONALD A. MARTELL Ronald A. Martell Chief Executive Officer |